FindTrial
Sign In

This study is to evaluate the anesthetic pain and discomfort during retinal photocoagulation.

Pre-emptive sub-conjunctival anaesthesia for Pan Retinal Photocoagulation.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/04/013173
Enrollment
30
Registered
2018-04-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Lignocaine 0.5 ml.: After a test dose lignocaine, patient will be given subconjunctival lignocaine 0.5 ml in one eye and sham injection in the other eye. Subsequently Pan Retinal Photoc

Sponsors

Giridhar Eye Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Proliferative Diabetic Retinopathy patients posted for Pan Retinal Photocoagulation in both eyes.

Exclusion criteria

Exclusion criteria: Recent history (less than one month) of ocular surgery in any one eye. Allergy to Lignocaine

Design outcomes

Primary

MeasureTime frame
Incidence of Pain.Timepoint: Incidence of Pain.—

Secondary

MeasureTime frame
Time duration of the procedure Severity of pain Quadrants of retina treated uninterruptedTimepoint: 8 months—

Countries

India

Contacts

Public ContactDr Rameez N Hussain

Giridhar Eye Institute

dr.rameezhussain@gmail.com9444527891

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026